Skip to main content
Premium Trial:

Request an Annual Quote

Zymo Research Gets CE-IVD Mark for SARS-CoV-2 Multiplex Kit

NEW YORK — Zymo Research said on Tuesday that it has received CE-IVD marking for its Quick SARS-CoV-2 Multiplex Kit.

The real-time reverse transcription PCR test is designed for the qualitative detection of SARS-CoV-2 nucleic acid in upper and lower respiratory specimens. According to the Irvine, California-based company, the kit has a limit of detection of 10-virus copies per reaction and up to 382 samples can be analyzed for each RT-PCR run.

In August, Zymo received CE-IVD marking for its Quick SARS-CoV-2 rRT-PCR kit, which received Emergency Use Authorization from the US Food and Drug Administration in May. 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.